Law360, New York (December 15, 2011, 6:06 PM EST) -- A plaintiff in a California proposed class action claiming Bayer HealthCare LLC falsely advertised the benefits of its digestive health supplements on Thursday failed in her bid to intervene in three similar New Jersey proposed class actions in order to dismiss or transfer them.
According to the suits, Bayer has marketed its Phillips Colon Health Probiotic products as scientifically proven to improve digestive function, despite having performed no clinical testing to back its claims.
U.S. Magistrate Judge Cathy Waldor of New Jersey federal court ruled that...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.